학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 127건 | 목록 1~20
News
Health & Medicine Week. September 26, 2011, p1382.
Academic Journal
van Gorkom G; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Van Elssen C; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Janssen I; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Groothuis S; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.; Evers S; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.; Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre of Economic Evaluation & Machine Learning, Maastricht, The Netherlands.; Bos G; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Academic Journal
van Gorkom G; Division of Hematology Department of Internal Medicine GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands.; Billen E; Division of Hematology Department of Internal Medicine GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands.; Van Elssen C; Division of Hematology Department of Internal Medicine GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands.; van Gelder M; Division of Hematology Department of Internal Medicine GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands.; Bos G; Division of Hematology Department of Internal Medicine GROW School for Oncology and Developmental Biology Maastricht University Medical Center Maastricht The Netherlands.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Academic Journal
Van Elssen C; Internal Medicine, Division of Hematology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, Netherlands. janine.van.elssen@mumc.nl.; van Gorkom G; Internal Medicine, Division of Hematology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, Netherlands.; Voorter C; Department of Transplantation Immunology, Maastricht University Medical Center, Maastricht, Netherlands.; von dem Borne P; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.; Meijer E; Department of Hematology, Amsterdam University Medical Center, Location VUMC, Cancer Center, Amsterdam, Netherlands.; Wieten L; Department of Transplantation Immunology, Maastricht University Medical Center, Maastricht, Netherlands.; Bos G; Internal Medicine, Division of Hematology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, Netherlands.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Academic Journal
van der Maas NG; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; Breems D; Department of Hematology, Ziekenhuis aan de Stroom, Cadix Hospital, Antwerp, Belgium.; Klerk CPW; Department of Internal Medicine, Dijklander Hospital, Amsterdam, The Netherlands.; Pabst T; Department of Medical Oncology, University Hospital, Inselspital, Bern, Switzerland.; Swiss Group for Clinical Cancer Research, SAKK, Bern, Switzerland.; Gradowska P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; HOVON Foundation, Rotterdam, The Netherlands.; Thomas A; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom.; Biemond BJ; Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Kuball J; Department of Hematology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.; Van Elssen CHMJ; Division Hematology, Department of Internal Medicine, GROW institute for Oncology and developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.; Vekemans MC; Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Graux C; Department of Hematology, Université Catholique de Louvain, University Hospital Center Namur (Godinne), Yvoir, Belgium.; Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.; Knapper S; School of Medicine, Cardiff University, Cardiff, United Kingdom.; Dennis M; Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom.; Freeman S; Department of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Thomas I; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom.; Beverloo HB; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Huls G; Department of Hematology, University Medical Center, University Groningen, Groningen, The Netherlands.; Craddock C; Warwick Clinical Trials Unit, University of Warwick, Warwick, United Kingdom.; Valk PJM; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Haematology, Oxford University Hospitals NHS Trust and Oxford Biomedical Centre, Oxford, United Kingdom.; Russell N; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Ossenkoppele G; Department of Hematology, Amsterdam University Medical Center, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Löwenberg B; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; Cornelissen JJ; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.; Versluis J; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Sponheimer M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; White K; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Ulrich M; Pfizer Inc, New York, New York, USA.; Kazerani M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Maiser A; Faculty of Biology and Center for Molecular Biosystems (BioSysM), LMU Munich, Munich, Germany.; Tyborski ET; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Rappa GP; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Richter D; Faculty of Biology, Anthropology & Human Genomics, LMU Munich, Munich, Germany.; Briem E; Faculty of Biology, Anthropology & Human Genomics, LMU Munich, Munich, Germany.; Hänel G; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Philipp N; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Nixdorf D; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Rohrbacher L; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Marcinek A; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Linder A; Department of Biochemistry, LMU Munich Gene Center, Munich, Germany.; Kuhl N; Department of Biochemistry, LMU Munich Gene Center, Munich, Germany.; Piseddu I; Department of Biochemistry, LMU Munich Gene Center, Munich, Germany.; Department of Medicine II, University Hospital LMU Munich, Munich, Germany.; Straub T; Bioinformatics Unit, LMU Munich, Munich, Germany.; Harz H; Faculty of Biology and Center for Molecular Biosystems (BioSysM), LMU Munich, Munich, Germany.; Wichmann C; Department of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital LMU Munich, Munich, Germany.; Maenner D; Department of Transfusion Medicine, Cell Therapeutics and Haemostaseology, University Hospital LMU Munich, Munich, Germany.; Rudelius M; Institute of Pathology, University Hospital LMU Munich, Munich, Germany.; Hornung V; Department of Biochemistry, LMU Munich Gene Center, Munich, Germany.; Leonhardt H; Faculty of Biology and Center for Molecular Biosystems (BioSysM), LMU Munich, Munich, Germany.; Van Elssen CHMJ; Department of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Research Institute for Oncology and Reproduction (GROW), Maastricht University, Maastricht, The Netherlands.; Abdelhamed S; Pfizer Inc, New York, New York, USA.; Diolaiti D; Pfizer Inc, New York, New York, USA.; Bücklein V; Department of Medicine III, University Hospital LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.; Subklewe M; Department of Medicine III, University Hospital LMU Munich, Munich, Germany marion.subklewe@med.uni-muenchen.de.; Laboratory for Translational Cancer Immunology, LMU Munich Gene Center Munich, Munich, Germany.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Versluis J; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Metzner M; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Wang A; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Gradowska P; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; HOVON Foundation, Rotterdam, the Netherlands.; Thomas A; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom.; Jakobsen NA; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Kennedy A; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Moore R; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Boertjes E; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Vonk CM; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Kavelaars FG; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Rijken M; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Gilkes A; School of Medicine, Cardiff University, Cardiff, United Kingdom.; Schwab C; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Beverloo HB; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Manz M; Department of Hematology, University Hospital Zurich, Zurich, Switzerland.; Visser O; Department of Hematology, Isala Hospital, Zwolle, the Netherlands.; Van Elssen CHMJ; Maastricht University Medical Center, Maastricht, the Netherlands.; de Weerdt O; Antonius Hospital, Nieuwegein, the Netherlands.; Tick LW; Maxima Medical Center, Eindhoven, the Netherlands.; Biemond BJ; Amsterdam UMC, Location AMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Vekemans MC; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Freeman SD; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; Harrison CJ; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.; Cook JA; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.; Dennis M; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Knapper S; School of Medicine, Cardiff University, Cardiff, United Kingdom.; Thomas I; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom.; Craddock C; Warwick Clinical Trials Unit, University of Warwick, Warwick, United Kingdom.; Ossenkoppele GJ; Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Löwenberg B; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Russell N; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Valk PJM; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.; Vyas P; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; Department of Haematology, Oxford University Hospitals NHS Trust and Oxford Biomedical Centre, Oxford, United Kingdom.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Van Elssen, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어